The Journal of Nutritional Biochemistry
Volume 20, Issue 12 , Pages 940-947 , December 2009

The role of diet in the metabolism of daidzein by human faecal microbiota sampled from Italian volunteers

  • Claudio Gardana

      Affiliations

    • Division of Human Nutrition, Department of Food Science and Microbiology, University of Milan, 20133 Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 02 50316072; fax: +39 02 50316071.
    • ,
  • Enrica Canzi

      Affiliations

    • Division of Microbiology, University of Milan, 20133 Milan, Italy
    • ,
  • Paolo Simonetti

      Affiliations

    • Division of Human Nutrition, Department of Food Science and Microbiology, University of Milan, 20133 Milan, Italy

Received 30 June 2008 ,Revised 14 August 2008 ,Accepted 15 August 2008.

References 

  1. Hwang CS, Kwak HS, Lim HJ, Lee SH. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem. 2006;101:246–253
  2. Mueller SO, Simon S, Chae K, Metzler M, Korach KS. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERα) and ERβ in human cells. Toxicol Sci. 2004;80:14–25
  3. DellaPenna D. Nutritional genomics: manipulating plant micronutrients to improve human health. Science. 1999;285:375–379
  4. Bairey Merz CN, Johnson BD, Braunstein GD, Pepine CJ, et al. Phytoestrogens and lipoproteins in women. J Clin Endocrinol Metab. 2006;91:2209–2213
  5. Alexandersen P, Haarbo J, Breinholt V, Christiansen C. Dietary phytoestrogens and estrogen inhibit experimental atherosclerosis. Climacteric. 2001;4:151–159
  6. Rice S, Mason HD, Whitehead SA. Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. J Steroid Biochem Mol Biol. 2006;101:216–225
  7. Wu J, Oka J, Higuchi M, Tabata I, Toda T, et al. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial. Metabolism. 2006;55:423–433
  8. Walsh KR, Haak SJ, Bohn T, Tian Q, et al. Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies. Am J Clin Nutr. 2007;85:1050–1056
  9. Zubik L, Meydani M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr. 2003;77:1459–1465
  10. Yuan JP, Wang JH, Liu X. Metabolism of dietary soy isoflavones to equol by human intestinal microflora-implications for health. Mol Nutr Food Res. 2007;51(7):765–781
  11. Rüfer CE, Glatt H, Kulling SE. Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography-mass spectrometry and high-performance liquid chromatography-mass spectrometry. Drug Metab Dispos. 2006;34(1):51–60
  12. Schmitt E, Dekant W, Stopper H. Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues. Toxicol In Vitro. 2001;15:433–439
  13. Mitchell JH, Gardner PT, McPhail DB, Morrice PC, et al. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys. 1998;360:142–148
  14. Setchell KDR, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol — A clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577–3584
  15. Hedlund TE, Johannes WU, Miller GJ. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate. 2003;54:68–78
  16. Setchell KDR, Clerici C, Lephart ED, Cole SJ, et al. S-Equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr. 2005;81:1072–1079
  17. Setchell KDR, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr. 2006;136:2188–2193
  18. Matthies AM, Clavel T, Gutschow M, Braune A, et al. Conversion of daidzein by a newly isolated anaerobic bacterium from mouse intestine. Appl Environ Microbiol. 2008;74(15):4847–4852
  19. Hur HG, Beger RD, Heinze TM, Lay JO, et al. Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein. Arch Microbiol. 2002;178:8–12
  20. Blackesmith SJ, Lyons-Wall PM, Joannou GE, Petocz P, Samman S. Urinary isoflavonoid excretion is inversely associated with the ratio of protein to dietary fiber intake in young women. Eur J Clin Nutr. 2005;59:284–290
  21. Rowland IR, Wiseman H, Sanders TA, Adlecreutz H, Boewy EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer. 2000;36:27–32
  22. Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med. 1998;217:335–339
  23. Hedlund TE, Maroni PD, Ferucci PG, Dayton R, et al. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in Caucasian men. J Nutr. 2005;135:1400–1406
  24. Lu LJ, Anderson KE. Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans. Am J Clin Nutr. 1998;68:1500S–1504S
  25. Decroos K, Vanhemmens S, Cattoir S, Boon N, Verstraete W. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch Microbiol. 2005;183:45–55
  26. Tokunaga T. Novel physiological function of fructooligosaccharides. BioFactors. 2004;21:89–94
  27. Uehara M, Ohta A, Sakai K, Suzuki K, et al. Dietary fructooligosaccharides modify intestinal bioavailability of a single dose of genistein and daidzein and affect their urinary excretion and kinetics in blood of rats. J Nutr. 2001;131:787–795
  28. Védrine N, Mathey J, Morand C, Brandolini M, et al. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women. Eur J Clin Nutr. 2006;60:1039–1045
  29. Tsangalis D, Wilcox G, Shah NP, McGill AE, Stojanovska L, et al. Urinary excretion of equol by postmenopausal women consuming soymilk fermented by probiotic bifidobacteria. Eur J Clin Nutr. 2007;61:438–441
  30. Porrini M, Gentile MG, Fidanza F. Biochemical validation of a self-administered semiquantitative food-frequency questionnaire. Br J Nutr. 1995;74:323–333
  31. Possemiers S, Bolca S, Eeckhaut E, Depypere H, Verstraete W. Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community. FEMS Microbiol Ecol. 2007;61:372–383
  32. Wang X, Hur H, Hyeon J, Lee HJ, Kim K, Kim S. Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium. Appl Environ Microbiol. 2005;71:214–219
  33. Song KB, Atkinson C, Frankenfeld CL, Jokela T, et al. Prevalence of daidzein metabolizing phenotypes between Korean American women and girls. J Nutr. 2006;136:1347–1351
  34. Atkinson C, Newton K, Bowles E, Yong M, Lampe J. Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States. Am J Clin Nutr. 2008;87:679–687
  35. Sofi F, Innocenti G, Dini C, Masi L, et al. Low adherence of a clinically healthy Italian population to nutritional recommendations for primary prevention of chronic diseases. Nutr Metab Cardiovasc Dis. 2006;16:436–444
  36. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione (INRAN) — Linee Guida per una Sana Alimentazione Italiana. Revision 2003. Available at http://www.inran.it.

PII: S0955-2863(08)00191-5

doi: 10.1016/j.jnutbio.2008.08.006

The Journal of Nutritional Biochemistry
Volume 20, Issue 12 , Pages 940-947 , December 2009

Article Tools

* Image Usage & Resolution